125 related articles for article (PubMed ID: 3015356)
1. Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Brain Res; 1986 Jul; 378(2):234-9. PubMed ID: 3015356
[TBL] [Abstract][Full Text] [Related]
2. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats.
Hiramatsu M; Nabeshima T; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1987 Dec; 28(4):489-94. PubMed ID: 2893389
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
Nabeshima T; Hiramatsu M; Kameyama T
Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
[TBL] [Abstract][Full Text] [Related]
4. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
Hiramatsu M; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):466-72. PubMed ID: 3020223
[TBL] [Abstract][Full Text] [Related]
5. Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):987-96. PubMed ID: 3572718
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
Slifer BL; Dykstra LA
Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481
[TBL] [Abstract][Full Text] [Related]
7. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
Holtzman SG
J Pharmacol Exp Ther; 1989 Mar; 248(3):1054-62. PubMed ID: 2539453
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists.
Leventer SM; Johnson KM
Life Sci; 1984 Feb; 34(8):793-801. PubMed ID: 6366418
[TBL] [Abstract][Full Text] [Related]
9. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum.
Nabeshima T; Yamaguchi K; Yamada K; Hiramatsu M; Furukawa H; Kameyama T
Eur J Pharmacol; 1983 Sep; 93(3-4):229-34. PubMed ID: 6416871
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic involvement in phencyclidine-induced behaviors.
Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
Hiramatsu M; Nabeshima T; Fukaya H; Furukawa H; Kameyama T
Eur J Pharmacol; 1986 Jan; 120(1):69-74. PubMed ID: 3456306
[TBL] [Abstract][Full Text] [Related]
13. Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.
Greenberg BD; Segal DS
Psychopharmacology (Berl); 1986; 88(1):44-53. PubMed ID: 3003779
[TBL] [Abstract][Full Text] [Related]
14. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats.
Nabeshima T; Yamada K; Yamaguchi K; Hiramatsu M; Furukawa H; Kameyama T
Eur J Pharmacol; 1983 Aug; 91(4):455-62. PubMed ID: 6684578
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
[TBL] [Abstract][Full Text] [Related]
16. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions.
Contreras PC; Rice KC; Jacobson AE; O'Donohue TL
Eur J Pharmacol; 1986 Feb; 121(1):9-18. PubMed ID: 3007170
[TBL] [Abstract][Full Text] [Related]
17. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
Turkish S; Cooper SJ
Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378
[TBL] [Abstract][Full Text] [Related]
18. Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation.
Altura BT; Altura BM; Quirion R
Br J Pharmacol; 1984 Jun; 82(2):459-66. PubMed ID: 6329394
[TBL] [Abstract][Full Text] [Related]
19. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
[TBL] [Abstract][Full Text] [Related]
20. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
